Sensitization of cancer cells for chemo/immuno/radio-therapy:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Totowa, NJ
Humana Press
2008
|
Schriftenreihe: | Cancer drug discovery and development series
|
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Includes bibliographical references and index |
Beschreibung: | XXI, 419 S. Ill., graph. Darst. |
ISBN: | 1934115290 9781934115299 |
Internformat
MARC
LEADER | 00000nam a2200000zc 4500 | ||
---|---|---|---|
001 | BV035415419 | ||
003 | DE-604 | ||
005 | 20090602 | ||
007 | t | ||
008 | 090403s2008 xxuad|| |||| 00||| eng d | ||
010 | |a 2008929553 | ||
015 | |a GBA854923 |2 dnb | ||
020 | |a 1934115290 |c alk. paper |9 1-934115-29-0 | ||
020 | |a 9781934115299 |c alk. paper |9 978-1-934115-29-9 | ||
035 | |a (OCoLC)209332297 | ||
035 | |a (DE-599)BVBBV035415419 | ||
040 | |a DE-604 |b ger |e aacr | ||
041 | 0 | |a eng | |
044 | |a xxu |c US | ||
049 | |a DE-355 |a DE-526 | ||
050 | 0 | |a RC271.C5 | |
082 | 0 | |a 616.99/4061 |2 22 | |
084 | |a XH 3100 |0 (DE-625)152887:12905 |2 rvk | ||
245 | 1 | 0 | |a Sensitization of cancer cells for chemo/immuno/radio-therapy |c ed. by Benjamin Bonavida |
264 | 1 | |a Totowa, NJ |b Humana Press |c 2008 | |
300 | |a XXI, 419 S. |b Ill., graph. Darst. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 0 | |a Cancer drug discovery and development series | |
500 | |a Includes bibliographical references and index | ||
650 | 4 | |a Drug resistance in cancer cells | |
650 | 4 | |a Radiation-sensitizing agents | |
650 | 4 | |a Antineoplastic agents |x Effectiveness | |
650 | 4 | |a Drug Resistance, Neoplasm | |
650 | 4 | |a Radiation-Sensitizing Agents | |
650 | 4 | |a Antineoplastic Agents |x therapeutic use | |
650 | 4 | |a Neoplasms |x drug therapy | |
650 | 4 | |a Neoplasms |x metabolism | |
650 | 4 | |a Radiotherapy |x methods | |
650 | 0 | 7 | |a Krebszelle |0 (DE-588)4128704-6 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Sensibilisator |0 (DE-588)4281065-6 |2 gnd |9 rswk-swf |
689 | 0 | 0 | |a Krebszelle |0 (DE-588)4128704-6 |D s |
689 | 0 | 1 | |a Sensibilisator |0 (DE-588)4281065-6 |D s |
689 | 0 | |C b |5 DE-604 | |
700 | 1 | |a Bonavida, Benjamin |e Sonstige |0 (DE-588)111806089 |4 oth | |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 1-597-45474-5 |
776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |z 978-1-597-45474-2 |
856 | 4 | 2 | |m Digitalisierung UB Regensburg |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017335938&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-017335938 |
Datensatz im Suchindex
_version_ | 1804138855529447424 |
---|---|
adam_text | Contents
Preface
..................................................................................................................................................
v
Part I Sensitization via Membrane-Bound Receptors
1.
Sensitization of Epithelial Cancer Cells with Human Monoclonal Antibodies
............................ 3
H. Peter
Vollmers
and Stephanie
Brändlein
2.
Targeting the Transferrin Receptor to Overcome Resistance to Anti-Cancer Agents
.................. 13
Tracy R. Daniels, Isabel I. Neacato, Gustavo Helguera, and Manuel L. Penichet
3.
Chemo-immunosensitization of Resistant B-NHL as a Result of Rituximab
(апи-СОгО
mAb)-Mediated Inhibition of Cell Survival Signaling Pathways
.............................. 29
Benjamin Bonavida,
AU R.
Jazirehi, Mario
I. Vega, Sara
Huerta-Yepez,
Kazno
Umezawa, and
Eriko
Suzuki
4.
Agents that Regulate DR5 and Sensitivity to TRAIL
................................................................... 41
Tatsushi Yoshida
and Toshiyuki Sakai
5.
Proteasome Inhibition: Potential for Sensitization of Immune Effector
Mechanisms in Cancer
.................................................................................................................. 51
Milad
Motarjemi, William H.D. Hallett, Minghui Li, and William J. Murphy
Part II Sensitization via Inhibition of Cell Survival Pathways
(Excluding Apoptotic Signaling Pathways)
6.
Angiogenesis Inhibitors as Enabling Agents for the Chemotherapeutic Treatment
of Metastatic Disease
.................................................................................................................... 63
Giulio Francia,
Urban Emmenegger, and Robert S.
Kerbel
1.
Targeting Survival Cascades Induced by Activation of Ras/Raf/MEK/ERK
and
РІЗК
/Akt
Pathways to Sensitize Cancer Cells to Therapy
.................................................... 81
James A. McCubrey, Richard A. Franklin, Fred E.
Bertrand,
Jackson R. Taylor,
William H. Chappell, Melissa L. Mid
gett,
Ellis W.T. Wong, Stephen L. A
bramš,
Kristin M. Stadelman, Negin Misaghian, Dale L.
Ludwig, Jörg Basecke,
Massimo Libra, Franca
Stivala, Michele Milella, Agostino
Tufuri,
Alberto
M.
Martelli, Paolo Lungi, Antonio Bonati, David M. Terrian,
Brian
D.
Lehmann,
and Linda
S. Steelman
IX
x
Contents
8.
Histone Deacetylase
Inhibitors
and Anticancer
Activity
............................................................ 115
Roberto R.
Rosato
and Steven Grant
9.
Eicosanoids and Resistance of Cancer Cells to Chemotherapeutic Agents
................................ 133
Andrey
Sorokin
Part III Sensitization via Transcription Factors
10.
The RKIP and STAT3 Axis in Cancer Chemotherapy: Opposites Attract
.................................. 159
Devasis Chatterjee,
Edmond
Sabo, Murray B. Resnick,
Кат С.
Yeung,
and
Y.
Eugene
Chin
ł
1.
Targeting Transcription Factors with Decoy Oligonucleotides:
Modulation of the Expression of Genes Involved in Chemotherapy
Resistance of Tumor Cells
.......................................................................................................... 175
Roberto Gambari
12.
p53 Inhibitors as Cancer Sensitizing Agents
.............................................................................. 189
Flavio
Maina
and Rosanna
Dono
13.
Nitric Oxide-Induced Immunosensitization to Apoptosis by Fas-L and TRAIL
....................... 203
Benjamin Bonavida, Sara Huerta-Yepez, Mario I.
Vega,
Demetrios
A. Spandidos, and Stravoula
Baritaki
14.
Natural Agents That Can Sensitize Tumor Cells to Chemotherapy
and Radiation Therapy
................................................................................................................ 211
Ganesh Jagetia, Sunil Krishnan, and Bharat B. Aggarwal
Part IV Sensitization via Targeting Apoptotic Pathways
15.
Inhibitors of the Bcl-2 Protein Family as Sensitizers to
Anticancer
Agents
.............................. 243
Daniel E. Johnson
16.
Therapeutic Targeting of Apoptosis in Cancer
........................................................................... 263
Timothy R. Wilson, Daniel B. Longley, and Patrick G. Johnston
17.
Peptides and Peptidomimetics as Cancer Therapy Sensitizing Agents
...................................... 279
Shantanu Banerji, Sudharsana Rao
Ande, Subbareddy
Maddika,
Versha Banerji, Iran Rashedi, Neil W. Owens, Anne Zuse,
Frank
Schweizer,
and
Marek Los
18.
Non-Peptidic Mimetics as Cancer-Sensitizing Agents
............................................................... 305
Ruud
P.M. Dings, Mark Klein, and Kevin H. Mayo
19.
Sensitization of Cancer Cells to Cancer Therapies by Isoflavone
and Its Synthetic Derivatives
...................................................................................................... 327
Fazlui H.
Sarkar
and
Yìwei Li
20.
Antisense Oligonucleotides and siRNA as Specific Inhibitors
of Gene Expression: Mechanisms of Action and Therapeutic Potential
.................................... 337
Yvonne
Förster
and
Bernd Schwenzer
Contents xi
Part V
Sensitization
Tailored to
Individual
Patients
21. DNA
Polymorphisms Affecting Chemosensitivity Toward Drugs
............................................. 365
Thomas Efferth and Michael Wink
22.
Pharmacogenetics in Cancer Management: Scenario for Tailored Therapy
............................... 389
Erika Cecchin,
Massimo Libra,
Calogero Cannavo,
Bibiana
Bruni,
Alberto Fulvi, Giuseppe Toffolì, and Franca Stivala
Index
.................................................................................................................................................... 405
|
any_adam_object | 1 |
author_GND | (DE-588)111806089 |
building | Verbundindex |
bvnumber | BV035415419 |
callnumber-first | R - Medicine |
callnumber-label | RC271 |
callnumber-raw | RC271.C5 |
callnumber-search | RC271.C5 |
callnumber-sort | RC 3271 C5 |
callnumber-subject | RC - Internal Medicine |
classification_rvk | XH 3100 |
ctrlnum | (OCoLC)209332297 (DE-599)BVBBV035415419 |
dewey-full | 616.99/4061 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 616 - Diseases |
dewey-raw | 616.99/4061 |
dewey-search | 616.99/4061 |
dewey-sort | 3616.99 44061 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02212nam a2200565zc 4500</leader><controlfield tag="001">BV035415419</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20090602 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">090403s2008 xxuad|| |||| 00||| eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="a">2008929553</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">GBA854923</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1934115290</subfield><subfield code="c">alk. paper</subfield><subfield code="9">1-934115-29-0</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781934115299</subfield><subfield code="c">alk. paper</subfield><subfield code="9">978-1-934115-29-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)209332297</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV035415419</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-526</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">22</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3100</subfield><subfield code="0">(DE-625)152887:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Sensitization of cancer cells for chemo/immuno/radio-therapy</subfield><subfield code="c">ed. by Benjamin Bonavida</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Totowa, NJ</subfield><subfield code="b">Humana Press</subfield><subfield code="c">2008</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XXI, 419 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Cancer drug discovery and development series</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug resistance in cancer cells</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiation-sensitizing agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic agents</subfield><subfield code="x">Effectiveness</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Neoplasm</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiation-Sensitizing Agents</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Antineoplastic Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">metabolism</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Radiotherapy</subfield><subfield code="x">methods</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebszelle</subfield><subfield code="0">(DE-588)4128704-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Sensibilisator</subfield><subfield code="0">(DE-588)4281065-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebszelle</subfield><subfield code="0">(DE-588)4128704-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Sensibilisator</subfield><subfield code="0">(DE-588)4281065-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Bonavida, Benjamin</subfield><subfield code="e">Sonstige</subfield><subfield code="0">(DE-588)111806089</subfield><subfield code="4">oth</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">1-597-45474-5</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="z">978-1-597-45474-2</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">Digitalisierung UB Regensburg</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017335938&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-017335938</subfield></datafield></record></collection> |
id | DE-604.BV035415419 |
illustrated | Illustrated |
indexdate | 2024-07-09T21:34:49Z |
institution | BVB |
isbn | 1934115290 9781934115299 |
language | English |
lccn | 2008929553 |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-017335938 |
oclc_num | 209332297 |
open_access_boolean | |
owner | DE-355 DE-BY-UBR DE-526 |
owner_facet | DE-355 DE-BY-UBR DE-526 |
physical | XXI, 419 S. Ill., graph. Darst. |
publishDate | 2008 |
publishDateSearch | 2008 |
publishDateSort | 2008 |
publisher | Humana Press |
record_format | marc |
series2 | Cancer drug discovery and development series |
spelling | Sensitization of cancer cells for chemo/immuno/radio-therapy ed. by Benjamin Bonavida Totowa, NJ Humana Press 2008 XXI, 419 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer drug discovery and development series Includes bibliographical references and index Drug resistance in cancer cells Radiation-sensitizing agents Antineoplastic agents Effectiveness Drug Resistance, Neoplasm Radiation-Sensitizing Agents Antineoplastic Agents therapeutic use Neoplasms drug therapy Neoplasms metabolism Radiotherapy methods Krebszelle (DE-588)4128704-6 gnd rswk-swf Sensibilisator (DE-588)4281065-6 gnd rswk-swf Krebszelle (DE-588)4128704-6 s Sensibilisator (DE-588)4281065-6 s b DE-604 Bonavida, Benjamin Sonstige (DE-588)111806089 oth Erscheint auch als Online-Ausgabe 1-597-45474-5 Erscheint auch als Online-Ausgabe 978-1-597-45474-2 Digitalisierung UB Regensburg application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017335938&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Sensitization of cancer cells for chemo/immuno/radio-therapy Drug resistance in cancer cells Radiation-sensitizing agents Antineoplastic agents Effectiveness Drug Resistance, Neoplasm Radiation-Sensitizing Agents Antineoplastic Agents therapeutic use Neoplasms drug therapy Neoplasms metabolism Radiotherapy methods Krebszelle (DE-588)4128704-6 gnd Sensibilisator (DE-588)4281065-6 gnd |
subject_GND | (DE-588)4128704-6 (DE-588)4281065-6 |
title | Sensitization of cancer cells for chemo/immuno/radio-therapy |
title_auth | Sensitization of cancer cells for chemo/immuno/radio-therapy |
title_exact_search | Sensitization of cancer cells for chemo/immuno/radio-therapy |
title_full | Sensitization of cancer cells for chemo/immuno/radio-therapy ed. by Benjamin Bonavida |
title_fullStr | Sensitization of cancer cells for chemo/immuno/radio-therapy ed. by Benjamin Bonavida |
title_full_unstemmed | Sensitization of cancer cells for chemo/immuno/radio-therapy ed. by Benjamin Bonavida |
title_short | Sensitization of cancer cells for chemo/immuno/radio-therapy |
title_sort | sensitization of cancer cells for chemo immuno radio therapy |
topic | Drug resistance in cancer cells Radiation-sensitizing agents Antineoplastic agents Effectiveness Drug Resistance, Neoplasm Radiation-Sensitizing Agents Antineoplastic Agents therapeutic use Neoplasms drug therapy Neoplasms metabolism Radiotherapy methods Krebszelle (DE-588)4128704-6 gnd Sensibilisator (DE-588)4281065-6 gnd |
topic_facet | Drug resistance in cancer cells Radiation-sensitizing agents Antineoplastic agents Effectiveness Drug Resistance, Neoplasm Radiation-Sensitizing Agents Antineoplastic Agents therapeutic use Neoplasms drug therapy Neoplasms metabolism Radiotherapy methods Krebszelle Sensibilisator |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=017335938&sequence=000004&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
work_keys_str_mv | AT bonavidabenjamin sensitizationofcancercellsforchemoimmunoradiotherapy |